Skip to main content
SpringerLink
Log in

Routine Coronary Arteriography Following Thrombolytic Therapy for Acute Myocardial Infarction: An Unsettled Controversy

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Although coronary artery disease remains the leading cause of death in industrialized countries, the management of patients recovering from acute myocardial infarction varies significantly. The issue of routine arteriography and revascularization following thrombolytic therapy remains controversial despite substantial evidence associating infarct-related artery patency with improved cardiac function and survival. Randomized trials of routine intervention after myocardial infarction have generally failed to demonstrate advantages of this invasive approach but methodological problems limit their application to current practice. High-risk patients should be referred for arteriography. While awaiting definitive trials addressing the influence of routine arteriography on patient survival and its cost effectiveness, the management of other patient groups must be individualized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565–572.

    Google Scholar 

  2. Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130–1135.

    Google Scholar 

  3. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573–578.

    Google Scholar 

  4. Kotler TS, Diamond GA. Exercise thallium-201 in the diagnosis and prognosis of coronary artery disease. Ann Intern Med 1990;113:684–702.

    Google Scholar 

  5. Kulick DL, Rahimtoola SH. Risk stratification in survivors of acute myocardial infarction: Routine cardiac catheterization and angiography is a reasonable approach in most patients. Am Heart J 1991;12:641–656.

    Google Scholar 

  6. Villella A, Maggioni AP, Villella M, et al. on behalf of the GISSI-2 investigators. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data base. Lancet 1995;346:523–529.

    Google Scholar 

  7. GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329: 1615–1622.

    Google Scholar 

  8. LATE study group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993;342:759–66.

    Google Scholar 

  9. EMERAS (Estuodio Multicentrico Estreptoquinasa Republicas de America del Sur). Randomized trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767–772.

    Google Scholar 

  10. Landau C, Lange RAS, Hill LD. Percutaneous transluminal coronary angioplasty. N Engl J Med 1994;330:981–993.

    Google Scholar 

  11. Anderson JL, Karagounis LA, Becker LC Sorenson SG, Menlove RL for the TEAM-3 investigators. TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Circulation 1993;87: 1829–1839.

    Google Scholar 

  12. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Engl J Med 1993;329:703–709.

    Google Scholar 

  13. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: A prospective placebo-controlled angiographic study. Circulation 1993;87:1524–1530.

    Google Scholar 

  14. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation 1993;88:2426–2436.

    Google Scholar 

  15. White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from acute myocardial infarction. Circulation 1987;76:44–51.

    Google Scholar 

  16. Lamas GA, Pfeffer MA. Increased left ventricular volume following myocardial infarction in man. Am Heart J 1986;111:30–35.

    Google Scholar 

  17. Jeremy RW, Allman K, Bautovich GB, Harris PJ. Patterns of left ventricular dilation during the six months after myocardial infarction. J Am Coll Cardiol 1989;13:304–309.

    Google Scholar 

  18. Taylor GJ, Humphries JO, Mellitis ED, et al. Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation 1980;62:960–970.

    Google Scholar 

  19. Norris RM, Barnaby PF, Brandt PWT, et al. Prognosis after recovery from first myocardial infarction: Determinants of reinfarction and sudden death. Am J Cardiol 1984;53: 408–413.

    Google Scholar 

  20. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. Circulation 1990;81:1161–1172.

    Google Scholar 

  21. Forman MB, Collins HW, Kopelman HA, et al. Determinants of left ventricular aneurysm formation after acute myocardial infarction: A clinical and angiographic study. J Am Coll Cardiol 1986;8:1256–1262.

    Google Scholar 

  22. Hirayama A, Adachi T, Asada S, et al. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size. Circulation 1993;88:2565–2574.

    Google Scholar 

  23. Nidorf SM, Siu SC, Balambos G, Wayman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol 1993;21:683–691.

    Google Scholar 

  24. Leung IH, Lau CP. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol 1992;20:307–313.

    Google Scholar 

  25. Schroder R, Neuhaus KL, Linderer T, Bruggemann T, Tebbe U, Wegscheider K. Impact of late coronary artery reperfusion on left ventricular function one month after acute myocardial infarction (results from the ISAM study). Am J Cardiol 1989;64:878–884.

    Google Scholar 

  26. Meijer A, Verheugt FWA, van Eenige MJ, Werter CJPJ. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation 1994;90:1706–1714.

    Google Scholar 

  27. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1–20.

    Google Scholar 

  28. Vermeer F, Simoons ML, Lubsen J. Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction. Lancet 1986;1:1147–1148.

    Google Scholar 

  29. Kersschot IE, Brugada P, Ramentol M, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: A prospective, randomized study. J Am Coll Cardiol 1986;7:1234–1242.

    Google Scholar 

  30. Sager PT, Perlmutter RA, Rosenfeld LE, McPherson CA, Wackers FJT, Batsford WP. Electrophysiologic effects of thrombolytic therapy in patients with a trasmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 1988;12:19–24.

    Google Scholar 

  31. Lange RA, Cigarroa RG, Wells PJ, Kremers MS, Hillis LD. Influence of anterograde flow in the infarct-related artery on the incidence of late potentials after acute myocardial infarction. Am J Cardiol 1990;65:554–558.

    Google Scholar 

  32. Vatterott PJ, Hammill SC, Bailey KR, Wiltgen CM, Gersh BJ. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol 1991;17: 330–337.

    Google Scholar 

  33. Kleiger RE, Miller PJ, Bigger JT, and the Multicenter Postinfarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987;59:256–262.

    Google Scholar 

  34. Odemuyiwa O, Jordaan P, Malik M, et al. Autonomic correlates of late infarct artery patency after first myocardial infarction. Am Heart J 1993;125:1957–1600.

    Google Scholar 

  35. Wilber DJ, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest: Use of electrophysiological testing in the prediction of long-term outcome.NEngl J Med 1988;318:19–24.

    Google Scholar 

  36. Ciggaroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol 1989;64: 155–160.

    Google Scholar 

  37. Galvani M, Ottani F, Ferrini D, Sorbello F, Rusticali F. Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarction. Am J Cardiol 1993;71:1–7.

    Google Scholar 

  38. Dalen JE, Gore JM, Braunwald E, and the TImyocardial infarction investigators. Six-and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TImyocardial infarction) trial. Am J Cardiol 1988;62:179–185.

    Google Scholar 

  39. Kennedy JW, Ritchie JL, Davis KB, Stadius ML, Maynard C, Fritz JK. The Western Washington trial of intra-coronary streptokinase in acute myocardial infarction: A 12 month follow up report. N Engl J Med 1985;312:1073–1078.

    Google Scholar 

  40. White HD, Cross DB, Elliott JM, Norris RM, Yee TW. Long-term importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994;89:61–67.

    Google Scholar 

  41. Lamas GA, Flaker GC, Mitchell G, et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation 1995;92:1101–1109.

    Google Scholar 

  42. Welty FK, Mittleman MA, Lewis SM, et al. A patent infarctrelated artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction 50%. Circulation 1996;93,1496–1501.

    Google Scholar 

  43. TIMI study group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989;320:618–627.

    Google Scholar 

  44. Terrin ML, Wiilliams DO, Kleiman NS, et al. Two-and threeyear results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. J Am Coll Cardiol 1993;22: 1763–1772.

    Google Scholar 

  45. SWIFT (Should We Intervene Following Thrombolysis?) trial study group. SWIFT trial of delayed elective intervention vs. conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. Br Med J 1991;302: 555–560.

    Google Scholar 

  46. Barbash GI, Roth A, Hod H, et al. Randomized controlled trial of late in-hospital arteriography versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:538–545.

    Google Scholar 

  47. Ellis SG, Mooney MR, George BS, et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Circulation 1992;86: 1400–1406.

    Google Scholar 

  48. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476–485.

    Google Scholar 

  49. Baim DS. Coronary angioplasty. In: Baim DS, Grossman W, eds. Cardiac Catheterization, Arteriography and Intervention, 5th ed. Baltimore, MD: Williams and Wilkins, 1996: 550–551.

    Google Scholar 

  50. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349–360.

    Google Scholar 

  51. Gruppo Italiano per lo Studio della Streprochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397–401.

    Google Scholar 

  52. Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 1995;123:873–877.

    Google Scholar 

  53. Every NR, Larson EB, Litwin PE, et al. The association between on-site cardiac catheterization facilities and the use of coronary arteriography after acute myocardial infarction. N Engl J Med 1993;329:546–551.

    Google Scholar 

  54. Lee TH. Cost effectiveness of tissue plasminogen activator. N Engl J Med 1995;332:1443–1444.

    Google Scholar 

  55. Kuntz KM, Tsevat J, Goldman L, Weinatein MC. Cost-effectiveness of routine coronary angiography after acute myocardial infarction. Circulation 1996;94:957–956.

    Google Scholar 

  56. Meyers DG. Relative survival benefits of risk factor modification. Am J Cardiol 1996;77:298–299.

    Google Scholar 

  57. Garber AM, Browner WS, Hulley SB. Cholesterol screening in asymptomatic adults, revisited. Ann Intern Med 1996;124: 518–531.

    Google Scholar 

  58. Manson JE, Tosteson H, Ridker PM, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326: 1406–1416.

    Google Scholar 

  59. Blair SN, Kohl HW, Barlow CE, et al. Changes in physical fitness and all-cause mortality. A prospective study of helthy and unhealthy men. JAMA 1995;273:1093–1098.

    Google Scholar 

  60. Sheperd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301–1307.

    Google Scholar 

  61. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:83–108.

    Google Scholar 

  62. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomized trials by the Coronary Artery Surgery Trialists Collaboration. Lancet 1994;344:563–570.

    Google Scholar 

  63. Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J. ςblockers and sudden death. Ann Intern Med 1995;123:358–367.

    Google Scholar 

  64. Simoons ML. Myocardial revascularization—bypass sugery or angioplasty? N Engl J Med 1996;335:275–276.

    Google Scholar 

  65. Thayssen P, Grande P, Madsen JK, et al. Improved clinical outcome following delayed coronary angioplasty after acute myocardial infarction, (abstr.) Circulation 1996;94 (Suppl.):I670.

    Google Scholar 

  66. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28:1328–1428.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel

    Amir Halkin & Ronen Jaffe

  2. Coronary Care Unit, Hadassah University Hospital, Mt. Scopus, Jerusalem, Israel

    A. Teddy Weiss & Doron Zahger

Authors
  1. Amir Halkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Teddy Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ronen Jaffe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Doron Zahger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halkin, A., Weiss, A.T., Jaffe, R. et al. Routine Coronary Arteriography Following Thrombolytic Therapy for Acute Myocardial Infarction: An Unsettled Controversy. J Thromb Thrombolysis 5, 183–189 (1998). https://doi.org/10.1023/A:1008872424033

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008872424033

Search

Navigation